IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.
If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!
Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.
Company: Veritone, Inc.
Symbol: VERI
Price: Last Trade $28.98
Trade Date: Week of 11/20
Shares: 0.8 million
Underwriter(s) : Roth Capital, Craig Hallum
Description: We have developed a proprietary artificial intelligence, or AI, platform that unlocks the power of cognitive computing to transform audio, video and other unstructured data and analyze it in conjunction with structured data in a seamless, orchestrated and automated manner to generate actionable intelligence.
Rating =Subscription Needed
Company: Mirati Therapeutics, Inc.
Symbol: MRTX
Price: Last Trade $14.05
Trade Date: 11/16
Shares: 5.4 million ($75 million cash raise)
Re-Offer Range: Subscription Needed
Underwriter(s) : Cowen, Barclays
Description: Mirati Therapeutics is a clinical-stage biotechnology company focused on developing a pipeline of targeted oncology products intended to treat specific genetic and epigenetic drivers of cancer.
Rating = Subscription Needed
Company: Norwegian Cruise Line – Block
Symbol: NCLH
Price: Last Trade $55.07
Trade Date: 11/16
Shares: 10 million
Re-Offer Range: Subscription Needed
Underwriter(s) : Morgan Stanley
Description: They are a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands.
Rating = Subscription Needed
Company: Talend SA
Symbol: TLND
Price: Last Trade $41.80
Trade Date: 11/16
Shares: 2.75 million
Re-Offer Range:Subscription Needed
Underwriter(s) : Citigroup, Barclays
Description: They are a next generation leader in cloud and big data integration solutions that helps companies become data driven by making data more accessible, improving its quality and quickly moving data where it’s needed for real-time decision making.
Rating = Subscription Needed
Company: AxoGen, Inc.
Symbol: AXGN
Price: Last Trade $24.90
Trade Date: 11/16
Shares: 1.2 million
Re-Offer Range: Subscription Needed
Underwriter(s) : Leerink
Co-Manager(s): JMP Securities, Cantor Fitzgerald
Description: AxoGen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair.
Rating = Subscription Needed